Clinical Trial Update: Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial of Inotuzumab ozogamicin combined with chemotherapy in leukemia and lymphoma patients undergoing stem cell transplantation was terminated, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoma

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2026-04-15